Article Text

Download PDFPDF

Review: ACE inhibitors delay microalbuminuria in diabetes without nephropathy and reduce mortality in diabetic nephropathy

Statistics from Altmetric.com


 
 Q Do antihypertensive agents prevent onset of microalbuminuria in patients with diabetes without nephropathy and delay progression in patients with diabetic nephropathy?

Clinical impact ratings GP/FP/Primary care ★★★★★★☆ IM/Ambulatory care ★★★★★★☆ Nephrology ★★★★★★☆ Cardiology ★★★★★★☆ Endocrine ★★★★★☆☆

METHODS

Embedded ImageData sources:

Medline (1966 to September 2003), EMBASE/Excerpta Medica (1988 to September 2003), Cochrane Central Register of Controlled Trials (2004), reference lists, and authors in the field.

Embedded ImageStudy selection and assessment:

randomised controlled trials (RCTs) in any language comparing an antihypertensive agent with another antihypertensive agent or placebo in diabetic patients with and without nephropathy. 16 RCTs (n = 8570) in diabetic patients without nephropathy and 43 RCTs (n = 7545) in diabetic patients with nephropathy met the selection criteria. Quality assessment of individual studies was based on allocation concealment, intention to treat analysis, loss to follow up, and blinding.

Embedded ImageOutcomes:

onset of microalbuminuria, all cause mortality, end stage renal disease …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.